Funded Startups in Burlingame
Burlingame’s most recent disclosed funding sizes span from $10K to $463M: Eolian’s $463M round (2025-10-09) is the clear outlier, sitting far above the nex…
Burlingame’s most recent disclosed funding sizes span from $10K to $463M: Eolian’s $463M round (2025-10-09) is the clear outlier, sitting far above the next-largest disclosed amounts such as Lyra Health at $235M (2022-01-19) and Corvus Pharmaceuticals at $201M (2026-01-21). That same “top-heavy” pattern shows up across industries, where the biggest entries are not confined to a single sector (e.g., energy via Eolian $463M; biotech via Corvus $201M; administrative services via Lyra Health $235M).
The 39 entries also cluster around recent time and repeated categories: the disclosed rounds cover 2020-05-27 through 2026-07-14, with the most recent dated entry being Quadric at $16M (2026-07-14). Sector-wise, AI appears repeatedly in the list (e.g., Quadric $16M on 2026-07-14; Butlr $33M on 2024-08-26; Signos $20M on 2023-10-24), and “Series Unknown” shows up across multiple rounds (e.g., Roadzen $8M on 2026-05-04; Cala Health $50M on 2026-04-20).
Most recent rounds
39 shownRelated listings
Frequently asked
Which disclosed round is the largest in Burlingame, and how does it compare to the rest of the disclosed amounts shown?
Eolian’s $463M disclosed round (2025-10-09) is the largest by a wide margin; the next-largest disclosed amounts in the table are Lyra Health at $235M (2022-01-19) and Corvus Pharmaceuticals at $201M (2026-01-21). The remaining top entries are far lower, including Aven ($110M on 2025-09-14) and Imply ($100M on 2022-05-17).
Do the biggest rounds cluster into a narrow time window, or are they spread out across years?
The largest disclosed rounds are spread across multiple years rather than concentrated in a tight window: Eolian is from 2025-10-09 ($463M), Lyra Health from 2022-01-19 ($235M), and Corvus from 2026-01-21 ($201M). The next tier includes earlier years as well, such as Proterra’s $200M on 2020-10-15 and Color’s $100M on 2021-11-09.
Are there sector over-representations among the repeated categories in this Burlingame list?
Artificial Intelligence (AI) appears multiple times across different stages and dates, including Quadric ($16M on 2026-07-14), Butlr ($33M on 2024-08-26), Inflammatix is biotech rather than AI but Lyra Health is administrative services, and Signos ($20M on 2023-10-24). Energy also shows up via Eolian ($463M on 2025-10-09) and Proterra ($200M on 2020-10-15), indicating at least two entries in that sector.
What stage/round naming pattern stands out for analysts scanning this list?
“Series Unknown” appears repeatedly across the 39 rows with disclosed amounts, including Roadzen ($8M on 2026-05-04) and Cala Health ($50M on 2026-04-20), plus other entries like Eolian ($463M on 2025-10-09). Several of the largest disclosed rounds are therefore not labeled with a standard series in the table (e.g., Eolian $463M, Corvus $201M, and Lyra Health is labeled Series F at $235M).
Which entries behave like outliers on the low end of disclosed funding?
xAI is the smallest disclosed amount shown at $10K (2024-11-20), which sits at the extreme low end compared with the rest of the disclosed amounts. Other small disclosed examples include Neurvona at $600K (2025-08-03) and Psyched Services at $300K (2025-02-26), but neither is close to xAI’s $10K floor.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.